BridgeMD
New treatment option for Neoplasms
Official title Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
ClinicalTrials.gov ID: NCT06482515
What this study is testing
- What it's testing
- Cancer-related fatigue affects at least 30-90% of patients with cancer, depending on the type of cancer and their treatment(s) (e.g., chemotherapy, radiation). It is not relieved by sleep or rest, and it sometimes can persist for years after a person's cancer was treated.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- (Participants must…):
- Have a diagnosis of a hematologic neoplasm (e.g., leukemia, lymphoma, multiple myeloma);
- Be at least 2 months post-treatment with chemotherapy, radiation, targeted therapy, chimeric antigen receptor (CAR)-T cell therapy, stem cell...
- Have a baseline level of fatigue, as determined by at least one of the following:
- Reporting a score of 4 or higher in response to the question, "What was your worst fatigue in the last week, on a scale of 0-10, where 0 is no...
You likely can't join if
- (participants must not…)
- Be underweight, as defined as a body mass index \<18.5 kg/m2;
- Already eat all their food within a window that is 10 h or shorter most (6/7) days of the week;
- Be employed in a job where they regularly work away from the home at night (e.g., night shift);
- Have surgery planned during the study duration;
- Have any contraindications to the proposed nutrition intervention as identified by their medical provider, their designee, or the study team (e.g...
See the full eligibility criteria
- (Participants must…):
- Have a diagnosis of a hematologic neoplasm (e.g., leukemia, lymphoma, multiple myeloma);
- Be at least 2 months post-treatment with chemotherapy, radiation, targeted therapy, chimeric antigen receptor (CAR)-T cell therapy, stem cell transplant, or another therapy (maintenance therapies are okay; steady...
- Have a baseline level of fatigue, as determined by at least one of the following:
- Reporting a score of 4 or higher in response to the question, "What was your worst fatigue in the last week, on a scale of 0-10, where 0 is no fatigue and 10 is the worst fatigue?"
- In the habit of taking daytime naps,
- Have fatigue that interferes with their ability to work, engage in social events, or is more than would be expected from physical exertion,
- Be able to speak and/or read and write in English or Spanish;
- Be at least 18 years old; and
- Be able to provide informed consent.
- (participants must not…)
- Be underweight, as defined as a body mass index \<18.5 kg/m2;
- Already eat all their food within a window that is 10 h or shorter most (6/7) days of the week;
- Be employed in a job where they regularly work away from the home at night (e.g., night shift);
- Have surgery planned during the study duration;
- Have any contraindications to the proposed nutrition intervention as identified by their medical provider, their designee, or the study team (e.g., type 1 diabetes, risk for hypoglycemia, medication requirements...
- Be taking insulin; or
- Be on enteral or parenteral nutrition.
The study team makes the final eligibility decision.
Where it's taking place
- Baltimore, Maryland, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Baltimore, Maryland, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.